The FTSE 100 has been flirting with the 6,900 level for much of this year.
Only last week, the UK’s leading index hit a 14-year high of 6,898.6, just 52 points below its 1999 all-time high of 6,950.
However, the impact of inflation means that comparisons with past values are largely irrelevant, despite their claimed ‘significance’.
After all, inflation means that £6,950 in 1999 was equivalent to approximately £10,000 today, suggesting that the FTSE 100 could be 30% cheaper than it was 14 years ago.
Is the FTSE cheap?
For investors in index-tracking funds such as the Vanguard FTSE 100 ETF (LSE: VUKE) or iShares FTSE 100 ETF (LSE: ISF), what’s important is how the FTSE is valued today — and what kind of dividend income can be expected:
|
FTSE 100 valuation |
Current value |
|
P/E |
13.8 |
|
Dividend yield |
3.4% |
Source: FT
Based on these figures, the FTSE is quite modestly valued, especially as these dividends are covered more than twice by earnings, on average.
Not quite that simple
Of course, it’s not quite that simple. The FTSE 100 is heavily weighted towards the oil, mining and financial sectors.
Royal Dutch Shell alone accounts for 14.5% of the FTSE 100’s total market capitalisation, while the next ten largest companies account for another 35%. This means that if you invest in a FTSE 100 tracker, 50% of your money will be invested in just 11 companies.
Given this, I think it’s worth taking a look at the average valuations of the companies in question, listed in descending size order:
|
Company |
2014 forecast P/E |
2014 prospective yield |
FTSE 100 weighting |
|
Royal Dutch Shell |
10.5 |
4.7% |
14.5% |
|
HSBC Holdings |
11.7 |
5.0% |
5.8% |
|
BHP Billiton |
11.9 |
4.2% |
4.6% |
|
BP |
9.3 |
5.4% |
4.0% |
|
Unilever |
20.3 |
3.3% |
3.6% |
|
GlaxoSmithKline |
15.1 |
5.6% |
3.2% |
|
British American Tobacco |
16.9 |
4.1% |
3.1% |
|
Rio Tinto |
9.8 |
4.1% |
2.7% |
|
AstraZeneca |
17.1 |
3.8% |
2.7% |
|
SABMiller |
21.2 |
2.1% |
2.5% |
|
Vodafone |
31.1 |
5.5% |
2.5% |
Source: Consensus forecasts
The largest four firms all have low valuations, which help keep the FTSE average P/E down, despite the fact that firms such as Unilever, AstraZeneca, British American Tobacco, SABMiller and Vodafone have much stronger valuations.
Looking at the figures in this way, it’s clear that not all companies in the FTSE 100 are cheap — far from it.
Is the FTSE a buy?
There’s no way of knowing what the FTSE 100 will do over the next year.
What is certain, however, is that a reliable yield of 3.4%, plus likely long-term capital appreciation, is considerably more than you’ll get from most savings accounts.
Of course, the main downside of sticking with a tracker is that you won’t be able to outperform the index — something that’s definitely possible with a portfolio of individual shares.
